Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

GigaCloud Technology's stock dip seems overblown, as the company exceeds Q3 forecasts. Learn why GCT stock is undervalued ...

Medical Properties Trust has made progress with liquidity but faces rising debt and asset write-downs. Learn why MPW stock ...

Morgan Stanley downgrades SolarEdge and Maxeon Solar Technologies amid uncertainty surrounding the Inflation Reduction Act, ...

Digital Turbine (APPS) shares fell around 3% on Friday after BofA downgraded its rating from Neutral to Underperform on the ...

Granite Construction is a top pick for roadwork investments as federal spending boosts infrastructure. Learn why GVA stock is ...

Nvidia Corporation's AI-driven growth is exceptional, projecting revenue growth and potential market cap increase in the ...

Disney's strong Q4 earnings and growth in ad-supported Disney+ subscribers are driving stock surge and profitability. See why ...

Pfizer's drug approvals and advertising revenue could be affected by RFK Jr.'s potential appointment. See why PFE stock is a ...

The rising dollar and interest rates create a triple threat of lower earnings, growth contraction, and falling P/E ratios.

Madison Square Garden Entertainment's latest earnings showed a slight revenue decline but beat expectations on adjusted ...

Despite strong financials, Montauk Renewables faces risks with its revenue sources and suppliers. Read why MNTK stock holds a ...